Back
Reinsurance Group of America Vs. Corcept Therapeutics Industry Stock Comparison
Buy
73
RGA
Reinsurance Group of America
Last Price:
218.69
Seasonality Move:
5.29%
Buy
68
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
Buy
73
Reinsurance Group of America (RGA)
is a Buy
Is Reinsurance Group of America a Buy, Sell or Hold?
- The current Reinsurance Group of America [RGA] share price is $218.50. The Score for RGA is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- RGA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $42.27. The Score for CORT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RGA Stock Price Chart
What is Reinsurance Group of America's stock price today?
-
The Reinsurance Group of America share price today is $218.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGA is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $42.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
RGA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.57 | Buy |
Relative Strength Index (14 RSI): | 58.27 | Buy |
Chaikin Money Flow: | 2816 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (208.49 - 217.45) | Buy |
Bollinger Bands (100): | (201 - 216.2) | Buy |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.36 | Buy |
Relative Strength Index (14 RSI): | 82.3 | Buy |
Chaikin Money Flow: | 670376 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.47 - 37.45) | Buy |
Bollinger Bands (100): | (28.16 - 35.86) | Buy |
RGA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 214.11 | Buy |
20-day SMA: | 214.41 | Buy |
50-day SMA: | 212.5 | Buy |
200-day SMA: | 191.71 | Buy |
8-day EMA: | 215.66 | Buy |
20-day EMA: | 214 | Buy |
50-day EMA: | 211.47 | Buy |
200-day EMA: | 193.39 | Buy |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.44 | Buy |
20-day SMA: | 35.75 | Buy |
50-day SMA: | 34.88 | Buy |
200-day SMA: | 28.43 | Buy |
8-day EMA: | 38.24 | Buy |
20-day EMA: | 36.43 | Buy |
50-day EMA: | 34.68 | Buy |
200-day EMA: | 30.05 | Buy |
Reinsurance Group of America Earnings Growth & RGA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.97 per share, an increase next quarter of $0.57 per share, an increase this year of $2.34 per share, and an increase next year of $0.96 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
Reinsurance Group of America Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |